Copyright (c) 2017 AJC
This work is licensed under a Creative Commons Attribution 4.0 International License.
in silico and Physico-Chemical Assessment of Effectiveness of Hydroxy/Amino Acids as Auxiliary Substances to Improve the Complexation Efficiency of b-Cyclodextrin Towards Bosentan
Corresponding Author(s) : Priyanka H. Jadhav
Asian Journal of Chemistry,
Vol. 29 No. 11 (2017): Vol 29 Issue 11
Abstract
The effectiveness of certain hydroxy and amino acids as an auxiliary substance to improve the complexation efficiency of b-cyclodextrin towards bosentan, a poorly soluble endothelin receptor antagonist, were assessed to enhance its physico-chemical performance. The phase solubility studies conducted in distilled water demonstrated a better choice of L-arginine as an auxiliary substance to improve complexation efficiency and association constant (Ks) of b-cyclodextrin. As a complementary evidence, in silico calculations were performed to foresee the stability, possible interactions and geometry of bosentan monohydrate inside b-cyclodextrin cavity, optimizing L-arginine again as an auxiliary substance. Subsequently, the solution state thermodynamic investigations revealed entropy driven complexation process. The lyophilized complexes were characterized by FTIR, DSC, XRPD and SEM. The performance of ternary complex was found to be appreciating in overall assessment, indicating better effectiveness of L-arginine as an auxiliary substance in improving complexation efficiency of b-cyclodextrin towards bosentan monohydrate.
Keywords
Download Citation
Endnote/Zotero/Mendeley (RIS)BibTeX
- C. Weber, R. Schmitt, H. Birnboeck, G. Hopfgartner, H. Eggers, J. Meyer, S. van Marle, H.W. Viischer and J.H.G. Jonkman, J. Clin. Pharmacol., 39, 703 (1999); https://doi.org/10.1177/00912709922008344.
- C. Weber, R. Schmitt, H. Birnboeck, G. Hopfgartner, S.P. van Marle, P.A.M. Peeters, J.H.G. Jonkman and C.-R. Jones, Clin. Pharmacol. Ther., 60, 124 (1996); https://doi.org/10.1016/S0009-9236(96)90127-7.
- T.K. Panda, D. Das and L. Panigrahi, J. Appl. Pharm. Sci., 6, 27 (2016); https://doi.org/10.7324/JAPS.2016.60904.
- M.R. Shah, S.P. Sancheti, V.M. Vyas, P.S. Karekar and Y.V. Pore, Drug Discov. Ther., 4, 70 (2010).
- T. Loftsson, D. Hreinsdottir and M. Masson, Int. J. Pharm., 302, 18 (2005); https://doi.org/10.1016/j.ijpharm.2005.05.042.
- O. Aleem, B. Kuchekar, Y. Pore and S. Late, J. Pharm. Biomed. Anal., 47, 535 (2008); https://doi.org/10.1016/j.jpba.2008.02.006.
- P. Gajare, C. Patil, N. Kalyanea and Y. Pore, Dig. J. Nanomater. Biostruct., 4, 891 (2009).
- P. Mura, M.T. Faucci and G.P. Bettinetti, Eur. J. Pharm. Sci., 13, 187 (2001); https://doi.org/10.1016/S0928-0987(01)00093-8.
- V. Pokharkar, A. Khanna, V. Venkatpurwar, S. Dhar and L. Mandpe, Acta Pharm., 59, 121 (2009); https://doi.org/10.2478/v10007-009-0001-3.
- M. Shah, P. Karekar, P. Sancheti, V. Vyas and Y. Pore, Drug Dev. Ind. Pharm., 1, 1 (2008).
- D. Bramhane, N. Saindane and P. Vavia, J. Incl. Phenom. Macrocycl. Chem., 69, 453 (2011); https://doi.org/10.1007/s10847-010-9783-7.
- A. Patil, Y. Pore and B. Kuchekar, Dig. J. Nanomater. Biostruct., 3, 89 (2008).
- L.S.S. Ribeiro, D.C. Ferreira and F.J.B. Veiga, Eur. J. Pharm. Sci., 20, 253 (2003); https://doi.org/10.1016/S0928-0987(03)00199-4.
- P. Jadhav and Y. Pore, Bull. Fac. Pharm. Cairo Univ., 55, 147 (2017); https://doi.org/10.1016/j.bfopcu.2016.12.004.
- P. Jadhav, B. Petkar, Y. Pore, A. Kulkarni and K. Burade, Carbohydr. Polym., 98, 1317 (2013); https://doi.org/10.1016/j.carbpol.2013.07.070.
- T. Higuchi and K.A. Connors, Adv. Anal. Chem. Instr., 4, 117 (1965).
- M. Brewster and T. Loftsson, Adv. Drug Deliv. Rev., 59, 645 (2007); https://doi.org/10.1016/j.addr.2007.05.012.
- C. dos Santos, M.P. Buera and M.F. Mazzobre, Procedia Food Sci., 1, 355 (2011); https://doi.org/10.1016/j.profoo.2011.09.055.
- S. Talegaonkar, Y. Khan, R.K. Khar, F.J. Ahmad and Z. Khan, Iran. J. Pharm. Res., 6, 95 (2007).
- A. Rasheed and C.A. Kumar, Int. J. Cur. Pharm. Res., 1, 47, (2009).
- S. Sapte and Y. Pore, J. Pharm. Anal., 6, 300 (2016); https://doi.org/10.1016/j.jpha.2016.03.004.
- L. Liu and Q. Guo, J. Phys. Chem. B, 103, 3461 (1999); https://doi.org/10.1021/jp984545f.
- M. Shah, Y. Pore, S. Dhawale, K. Burade and B. Kuchekar, J. Incl. Phenom. Macrocycl. Chem., 76, 391 (2013); https://doi.org/10.1007/s10847-012-0211-z.
- D. Doiphode, S. Gaikwad, Y. Pore, B. Kuchekar and S. Late, J. Incl. Phenom. Macrocycl. Chem., 62, 43 (2008); https://doi.org/10.1007/s10847-008-9435-3.
- V. Shinde, M. Shelake, S. Shetty, A. Chavan-Patil, Y. Pore and S. Late, J. Pharm. Pharmcol., 60, 1121 (2008); https://doi.org/10.1211/jpp.60.9.0002.
References
C. Weber, R. Schmitt, H. Birnboeck, G. Hopfgartner, H. Eggers, J. Meyer, S. van Marle, H.W. Viischer and J.H.G. Jonkman, J. Clin. Pharmacol., 39, 703 (1999); https://doi.org/10.1177/00912709922008344.
C. Weber, R. Schmitt, H. Birnboeck, G. Hopfgartner, S.P. van Marle, P.A.M. Peeters, J.H.G. Jonkman and C.-R. Jones, Clin. Pharmacol. Ther., 60, 124 (1996); https://doi.org/10.1016/S0009-9236(96)90127-7.
T.K. Panda, D. Das and L. Panigrahi, J. Appl. Pharm. Sci., 6, 27 (2016); https://doi.org/10.7324/JAPS.2016.60904.
M.R. Shah, S.P. Sancheti, V.M. Vyas, P.S. Karekar and Y.V. Pore, Drug Discov. Ther., 4, 70 (2010).
T. Loftsson, D. Hreinsdottir and M. Masson, Int. J. Pharm., 302, 18 (2005); https://doi.org/10.1016/j.ijpharm.2005.05.042.
O. Aleem, B. Kuchekar, Y. Pore and S. Late, J. Pharm. Biomed. Anal., 47, 535 (2008); https://doi.org/10.1016/j.jpba.2008.02.006.
P. Gajare, C. Patil, N. Kalyanea and Y. Pore, Dig. J. Nanomater. Biostruct., 4, 891 (2009).
P. Mura, M.T. Faucci and G.P. Bettinetti, Eur. J. Pharm. Sci., 13, 187 (2001); https://doi.org/10.1016/S0928-0987(01)00093-8.
V. Pokharkar, A. Khanna, V. Venkatpurwar, S. Dhar and L. Mandpe, Acta Pharm., 59, 121 (2009); https://doi.org/10.2478/v10007-009-0001-3.
M. Shah, P. Karekar, P. Sancheti, V. Vyas and Y. Pore, Drug Dev. Ind. Pharm., 1, 1 (2008).
D. Bramhane, N. Saindane and P. Vavia, J. Incl. Phenom. Macrocycl. Chem., 69, 453 (2011); https://doi.org/10.1007/s10847-010-9783-7.
A. Patil, Y. Pore and B. Kuchekar, Dig. J. Nanomater. Biostruct., 3, 89 (2008).
L.S.S. Ribeiro, D.C. Ferreira and F.J.B. Veiga, Eur. J. Pharm. Sci., 20, 253 (2003); https://doi.org/10.1016/S0928-0987(03)00199-4.
P. Jadhav and Y. Pore, Bull. Fac. Pharm. Cairo Univ., 55, 147 (2017); https://doi.org/10.1016/j.bfopcu.2016.12.004.
P. Jadhav, B. Petkar, Y. Pore, A. Kulkarni and K. Burade, Carbohydr. Polym., 98, 1317 (2013); https://doi.org/10.1016/j.carbpol.2013.07.070.
T. Higuchi and K.A. Connors, Adv. Anal. Chem. Instr., 4, 117 (1965).
M. Brewster and T. Loftsson, Adv. Drug Deliv. Rev., 59, 645 (2007); https://doi.org/10.1016/j.addr.2007.05.012.
C. dos Santos, M.P. Buera and M.F. Mazzobre, Procedia Food Sci., 1, 355 (2011); https://doi.org/10.1016/j.profoo.2011.09.055.
S. Talegaonkar, Y. Khan, R.K. Khar, F.J. Ahmad and Z. Khan, Iran. J. Pharm. Res., 6, 95 (2007).
A. Rasheed and C.A. Kumar, Int. J. Cur. Pharm. Res., 1, 47, (2009).
S. Sapte and Y. Pore, J. Pharm. Anal., 6, 300 (2016); https://doi.org/10.1016/j.jpha.2016.03.004.
L. Liu and Q. Guo, J. Phys. Chem. B, 103, 3461 (1999); https://doi.org/10.1021/jp984545f.
M. Shah, Y. Pore, S. Dhawale, K. Burade and B. Kuchekar, J. Incl. Phenom. Macrocycl. Chem., 76, 391 (2013); https://doi.org/10.1007/s10847-012-0211-z.
D. Doiphode, S. Gaikwad, Y. Pore, B. Kuchekar and S. Late, J. Incl. Phenom. Macrocycl. Chem., 62, 43 (2008); https://doi.org/10.1007/s10847-008-9435-3.
V. Shinde, M. Shelake, S. Shetty, A. Chavan-Patil, Y. Pore and S. Late, J. Pharm. Pharmcol., 60, 1121 (2008); https://doi.org/10.1211/jpp.60.9.0002.